This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
electric-vehicles: Archive
Is Rivian Stock a Buy as R2 Growth Collides With Heavy Cash Burn?
by Rimmi Singhi
Rivian's R2 ramp and software gains support growth, but heavy cash burn, execution risks and elevated capital needs keep the stock a Hold.
RIVNNegative Net Change VWAGYNegative Net Change UBERPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles transportation
Tesla-SpaceX Terafab Bet: 4 Chip Equipment Stocks That Could Benefit
by Rimmi Singhi
Terafab buildout could create major opportunities for KLA, Onto, Applied Materials and Lam Research as AI chip capacity expands.
KLACNegative Net Change LRCXNegative Net Change AMATNegative Net Change TSLAPositive Net Change ONTONegative Net Change SPCXNegative Net Change
aerospace artificial-intelligence communications computers electric-vehicles semiconductor tech-stocks
Can Ford's Sub-$30K Fathom Succeed Where the F-150 Lightning Failed?
by Rimmi Singhi
F's sub-$30K Fathom targets affordability, manufacturing efficiency and profitability after the costly F-150 Lightning setback.
FPositive Net Change NSANYPositive Net Change GMPositive Net Change
auto-tires-trucks electric-vehicles
Manhattan Associates (MANH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MANHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Wex (WEX) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WEXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Medpace (MEDP) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
MEDPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Motorola (MSI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
MSINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla or SpaceX: Which Musk-Led Company is a Better Investment Now?
by Rimmi Singhi
TSLA and SPCX offer high-growth exposure to AI, autonomy, satellites and space, but steep valuations and heavy spending raise investment risks.
TSLAPositive Net Change SPCXNegative Net Change
aerospace artificial-intelligence autonomous-vehicles communications electric-vehicles self-driving-cars tech-stocks
CVNA Q2 Earnings Meet Estimates, Revenues Beat on Unit Growth
by Zacks Equity Research
Carvana's Q2 revenues jump 52% on record retail volume and strong pricing, while EBITDA grows despite margin pressure from expansion investments.
CVNAPositive Net Change FPositive Net Change GMPositive Net Change TSLAPositive Net Change
auto-tires-trucks earnings electric-vehicles retail
LCID Q2 Earnings Miss on Inventory Charges, Revenues Beat Estimates
by Zacks Equity Research
Lucid's Q2 revenues jump 56.2% and beat estimates, but a $300 million inventory charge widens losses and keeps margins deeply negative.
LCIDNegative Net Change FPositive Net Change GMPositive Net Change TSLAPositive Net Change
auto-tires-trucks earnings electric-vehicles